These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Procoagulant activity in glomeruli and urine of rabbits with nephrotoxic nephritis. Wiggins RC; Glatfelter A; Brukman J Lab Invest; 1985 Aug; 53(2):156-65. PubMed ID: 4021444 [TBL] [Abstract][Full Text] [Related]
3. Does t-PA have a role in the treatment of crescentic glomerulonephritis? McCluskey RT; Andres GA Lab Invest; 1990 Jan; 62(1):1-4. PubMed ID: 2104944 [No Abstract] [Full Text] [Related]
4. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Erlich JH; Holdsworth SR; Tipping PG Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825 [TBL] [Abstract][Full Text] [Related]
5. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats. Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997 [TBL] [Abstract][Full Text] [Related]
6. Crescentic glomerulonephritis in interferon-gamma receptor deficient mice. Haas C; Ryffel B; Le Hir M J Inflamm; 1995-1996; 47(4):206-13. PubMed ID: 9144077 [TBL] [Abstract][Full Text] [Related]
7. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850 [TBL] [Abstract][Full Text] [Related]
8. Tissue factor: biological function and clinical significance. Lwaleed BA Saudi Med J; 2002 Feb; 23(2):135-43. PubMed ID: 11938386 [TBL] [Abstract][Full Text] [Related]
9. A new look into the pathogenesis of glomerular disease. Futrakul P J Med Assoc Thai; 1971 Apr; 54(4):262-5. PubMed ID: 5563458 [No Abstract] [Full Text] [Related]
10. Spontaneous release of interleukin-8 by glomerular macrophages from patients with rapidly progressive crescentic glomerulonephritis. Matsumoto K Nephrol Dial Transplant; 1994; 9(11):1693. PubMed ID: 7870365 [No Abstract] [Full Text] [Related]
11. Chronic autologous immune complex glomerulopathy: effect of cyproheptadine. Bolton WK; Spargo BA; Lewis EJ J Lab Clin Med; 1974 May; 83(5):695-704. PubMed ID: 4821854 [No Abstract] [Full Text] [Related]
12. Glomerulonephritis: the lesions produced and how they are produced. Gwavava NJ; Muronda C Cent Afr J Med; 1982 Apr; 28(4):89-93. PubMed ID: 7127446 [No Abstract] [Full Text] [Related]
13. Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy. Taniguchi Y; Yorioka N; Kumagai J; Ito T; Yamakido M; Taguchi T Clin Nephrol; 1999 Oct; 52(4):253-5. PubMed ID: 10543328 [TBL] [Abstract][Full Text] [Related]
14. [Changes in blood coagulation in glomerulonephritis]. Robeva R; Belovezhdov N; Genova V Vutr Boles; 1982; 21(6):1-7. PubMed ID: 6219496 [No Abstract] [Full Text] [Related]
15. [Eicosanoids and glomerular disease]. Kuroda M Nihon Rinsho; 1990 Jun; 48(6):1270-5. PubMed ID: 2384974 [No Abstract] [Full Text] [Related]
18. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats. Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492 [TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis and anticoagulant treatment of autoimmune diseases of the kidneys (review of the literature)]. Shul'tsev GP; Gilunova NI; Tsalenchuk IaP Ter Arkh; 1971 Nov; 43(11):18-23. PubMed ID: 4948318 [No Abstract] [Full Text] [Related]